
Learn the Targeted Muscle Reinnervation (TMR) for neuroma treatment following above knee amputation surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Targeted Muscle Reinnervation (TMR) for neuroma treatment following above knee amputation surgical procedure.
There are various potential sources of chronic nerve pain following amputation but approximately one quarter of lower limb amputees will develop chronic nerve pain specifically due to a symptomatic neuroma within the stump. Chronic nerve pain is a major source of disability in some patients following limb amputation, reducing engagement with rehabilitation programmes and tolerance of prosthetic use. There is an accompanying burden of psychosocial morbidity.
Treatment of symptomatic neuromas is a challenge for the whole pain team as well as the peripheral nerve surgeon.
Various surgical techniques are described, and varying degrees of success reported for each.
During lower limb amputation surgery peripheral nerves are often divided under traction, allowing them to retract away from the stump into healthier tissue. This method however can lead to neuroma formation with spontaneous and evoked pain as well as allodynia, hyperalgesia and dysaesthesia, hallmarks of central sensitisation.
Surgical treatment for an end neuroma may involve use of a capping device, burial of the stump within muscle or within a cortical bone window or anastomosis to another nerve or a a long nerve ‘graft to nowhere’. Results of these techniques are inconsistent, and treatment of these patients remains difficult.
Targeted muscle reinnervation (TMR) involves a nerve transfer of the residual nerve end to a motor nerve that is no longer useful. This is performed as close as possible to its entry point into the muscle.
TMR has shown success in the upper limb where it has been used to generate physiologically appropriate electromyography signals within muscles of the residual limb for prosthetic control. Significant reductions in neuroma pain have also been noted in these patients.
Early results of TMR in the lower limb have shown promise in preventing or treating neuroma pain. It may be offered at the time of amputation as a preventative measure, or in the treatment of established, symptomatic neuroma in an amputation stump.
Coapting sectioned nerve stumps onto recipient motor nerve branches encourages nerve regeneration into the target muscle, preventing the formation or recurrence of neuroma.
In this section the workup and surgical technique in a patient with an established end neuroma following an above knee amputation stump is described.
Readers will also find the following OrthOracle surgical techniques of interest:
Targeted Muscle Reinnervation (TMR) of Superficial Radial Nerve using Axogen Avance processed nerve allograft
Excision of a sural nerve end neuroma and application of a Polyganics NeuroCapTM
Below knee amputation

INDICATIONS
In a lower limb amputation stump, targeted muscle reinnervation (TMR) is indicated whenever there is a symptomatic end neuroma that can be identified.
The technique of TMR is proven in prevention of neuromas and phantom pain in primary amputation as well as in secondary intervention for neuroma pain after amputation. In the lower limb, TMR has been used primarily to redirect axons from a mixed motor-sensory nerve stump after transection to a motor branch in the vicinity of the amputation to goo effect. When there are no motor branches available, or the risk of muscle wasting and therefore prosthetic fitting or padding is a concern, then development of a reconstructive peripheral nerve interface (RPNI) may be preferred. Osteointegration may be used to improve prosthetic interface with the skeleton in cases with poor muscle bulk, in short stomps and in cases where there is neuroma pain from a traditional socket interface.
The indications for TMR are an established symptomatic neuroma after previous surgery, or a nerve transection injury that does not have a suitable distal nerve stump available for active reconstruction with a nerve graft.
SYMPTOMS & EXAMINATION
A quarter of lower limb amputees report localised neuroma pain within the stump. This can be difficult to differentiate from phantom limb sensations that are referred to the amputated part.
Pain from an end neuroma within the stump manifests as a combination of pain that is evoked by local touch or pressure that stimulates local nerve endings within the neuroma. There is, in addition, the presence of spontaneous pain that the patient may describe as coming on at rest without any obvious trigger. The pain may be described as an electric shock, shooting burning, or tingling sensation. The effected area may also exhibit features of central sensitisation such as:
Allodynia : Pain elicited by normally innocuous stimulation
Hyperalgesia : Exaggerated and prolonged response to pain
Secondary hyperalgesia : Pain that spreads beyond the original site of stimulation
Examination in this group of patients can be difficult due to the exaggerated pain response and possible psychological distress with apprehension. It is helpful to reserve examination of the most sensitive areas of the stump to the end of the examination as once pain is initiated it may make the rest if the examination unreliable even if the patient can tolerate it.
Gentle tapping in a distal to proximal direction along the courses of the main nerve trunks may elicit a Tinels sign over the neuroma.
If there is tether pain due to a sensitised nerve end that is stuck in a scarred bed, movement of the residual limb may elicit pain.
An assessment of the skin quality and scars over the stump must also be made. A tender scar or poorly fashioned amputation stump may contribute to pain after an amputation and the opinion of the patients orthopaedic surgeon and prosthetist should be sought before planning any nerve surgery.
INVESTIGATIONS
The principle investigation in this group of patients is a series of ultrasound guided nerve block with pain scores using a visual analogue scale before and after each block. This helps to confirm the distribution of pain within the various transected nerve trunks and helps confirm which trunks have a neuroma that is a significant pain driver. It also helps determine whether more than one nerve is involved in a territory where neighbouring nerves may be contributing to pain together.
In this particular case the sciatic and saphenous nerve branches were considered to be the main pain drivers.
Therefore the sciatic, saphenous, posterior cutaneous femoral nerve and femoral nerves were blocked in turn with pain scoring between each individual block. Other candidates for nerve block include the lateral cutaneous nerve of thigh and the obturator nerve but neither correlated clinically with the distribution of pain.
After blockade in the order above pain was abolished after the saphenous nerve block with minimal contributions from the remaining nerves.
Ultrasound imaging of the stump may help locate the presence and location an end neuroma which may be lying out of its normal anatomical location particularly after being divided under traction.
ALTERNATIVE OPERATIVE TREATMENT
There are a great many alternative surgical treatments for neuroma management with variable results in the published literature. These have include treating the end neuroma with a nerve capping device, burial of the nerve stump into a cortical window, or local muscle. Long grafts to nowhere, recently using Avance allograft have also been described. Comprehensive pain scoring before and after surgical intervention and long term follow up are essential to fully evaluate any technique.
NON-OPERATIVE MANAGEMENT
Non surgical modes of treatment have often been exhausted by the time a patient arrives at a peripheral nerve clinic. However a period of desensitisation therapy that includes local soft tissue mobilisation, scar massage and desensitisation is important. Where there is central sensitisation, the patient should see an appropriate occupational therapist for mirror therapy alongside a desensitisation programme.
Pharmacological treatment may include the use of neuropathic pain agents such as Gabapentin. The full guidance about use of these medications is set out in NICE guideline CG173.
Psychological therapies are helpful in a subset of patients that demonstrate features of significant psychological distress, but these should be seen as an adjunctive measure alongside treatment of a symptomatic neuroma
CONTRAINDICATIONS
Contraindications to surgery include any general concerns about surgery such as poor skin quality or active infection.
A poor response to the diagnostic blocks would raise concerns about the likely success of surgical intervention. Significant psychological distress in any patient should also raise concerns about the success of a purely surgical approach and an initial psychological assessment is important.

The patient is under a general anaesthetic without muscle relaxant since it is helpful to have reliable nerve stimulation.
Once the procedure is complete, a local anaesthetic catheter can be left in situ to provide intermittent post operative analgesia for the first 24 hours.
The patient is positioned supine with the thigh draped off as high into the groin as possible.
Thrombo-prophylaxis and prophylactic antibiotics are given according to local protocol.
Both bipolar and unipolar diathermy and suction are be available.
Once nerves are exposed, a pair of mixter forceps and several sloops will be required. A set of micro-instruments with jewellers forceps and serrated nerve scissors. A neurotomy set can be added to this if available.
A microscope which should be checked and setup for the correct focal length, inter pupillary distance and working position prior to starting the procedure.
Nerve coaptation is made using 9/0 nylon and fibrin glue (Tisseal – Baxter).

Once recovered from the general anaesthetic the patient is returned to the ward. If pain is well controlled the patient can mobilise safely with input from the ward physiotherapists.
The patient is typically discharged the next morning after removal of the nerve catheter on the ward.
The first follow up clinic appointment is in one week, when the dressings are removed and an initial post operative pain score is recorded.
At two weeks the wound is sealed and the dressings can be reduced.
Prosthetic fitting, or resumed prothetic use may be commenced once the wound is resilient after 6- 8 weeks provided the wound is well healed and the patient feels ready to do so.
Liaison with the patients prosthetist throughout is essential to ensure satisfactory outcomes.
Further follow up with repeat pain scoring is scheduled for 3 months, 6 months and 1 year postoperatively.

1. Targeted Muscle Reinnervation for the Upper and Lower Extremity. Kuiken TA, Barlow AK, Hargrove L, Dumanian GA.
Tech Orthop. 2017 Jun;32(2):109-116.
An overview of the use of targetted muscle reinnervation and its role in both prosthetic control and neuroma prevention.
2. Preemptive Treatment of Phantom and Residual Limb Pain with Targeted Muscle Reinnervation at the Time of Major Limb Amputation. Valerio IL, Dumanian GA, Jordan SW, Mioton LM, Bowen JB, West JM, Porter K, Ko JH, Souza JM, Potter BK.
J Am Coll Surg. 2019 Mar;228(3):217-226.
There is an increasing recognition that TMR performed at the same time as a limb amputation may prevent the onset of neuropathic pain.
In this cohort study fifty one patients were compared with a larger historical control group showing significant reductions in neuropathic pain in the TMR group.
3.Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial.
Dumanian GA, et al. Apkarian AV, Porter K, Jordan SW.Ann Surg. 2019 Aug;270(2):238-246.
This RCT compared conventional neurectomy with TMR for the treatment of chronic post amputation pain showed significantly greater improvements in pain scores in the TMR group.
Reference
- orthoracle.com



































